XML 33 R22.htm IDEA: XBRL DOCUMENT v3.21.1
Common Stock and Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Common Stock Shares Reserved for Issuance

As of each balance sheet date, the Company had reserved shares of common stock for issuance in connection with the following:

 

 

 

March 31, 2021

 

 

December 31, 2020

 

Conversion of outstanding shares of convertible

   preferred stock

 

 

 

 

 

16,079,230

 

Options outstanding under incentive award plans

 

 

2,544,778

 

 

 

2,466,670

 

Shares available for future grant under incentive award plans

 

 

2,327,433

 

 

 

17,556

 

Shares available for future grant under employee stock purchase plans

 

 

240,000

 

 

 

 

Total shares reserved

 

 

5,112,211

 

 

 

18,563,456

 

Summary of Stock Option Activity

The following table summarizes the stock option activity for all stock plans during the quarter ended March 31, 2021:

 

 

 

Number

of Shares

 

 

Weighted-

Average

Exercise

Price

 

 

Weighted-

Average

Remaining

Contractual

Term

 

 

Aggregate

Intrinsic

Value

 

 

 

 

 

 

 

 

 

 

 

(in years)

 

 

(in thousands)

 

Outstanding as of December 31, 2020

 

 

2,466,670

 

 

$

8.03

 

 

 

9.61

 

 

$

21,678

 

Granted

 

 

106,000

 

 

 

20.12

 

 

 

 

 

 

 

 

Forfeited

 

 

(27,892

)

 

 

7.18

 

 

 

 

 

 

 

 

Outstanding as of March 31, 2021

 

 

2,544,778

 

 

$

8.57

 

 

 

8.64

 

 

$

33,976

 

Exercisable, March 31, 2021

 

 

2,009,995

 

 

$

8.16

 

 

 

8.67

 

 

$

27,742

 

Vested and expected to vest, March 31, 2021

 

 

2,544,778

 

 

$

8.57

 

 

 

8.64

 

 

$

33,976

 

Schedule of Stock Options Weighted Average Assumptions

  The Company estimated the fair value of options granted using a Black-Scholes option pricing model with the following assumptions presented on a weighted average basis:

 

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

Expected option life

 

 

5.95

 

 

 

5.88

 

Expected volatility

 

 

66.70

%

 

 

59.95

%

Risk-free interest rate

 

 

0.76

%

 

 

0.58

%

Expected dividend yield

 

 

%

 

 

%

Fair value of underlying common stock

 

$

20.13

 

 

$

9.24

 

Fair value of option

 

$

11.94

 

 

$

5.67

 

Summary of Restricted Stock Award Activity

The following table summarizes the stock award activity for all stock plans during the quarter ended March 31, 2021:

 

 

 

Number

of Shares

 

 

Grant-Date

Fair Value

 

Unvested restricted common stock as of December 31, 2020

 

 

83,334

 

 

$

1.96

 

Forfeited

 

 

(11,905

)

 

 

1.96

 

Unvested restricted common stock as of March 31, 2021

 

 

71,429

 

 

$

1.96

 

Schedule of Stock-based Compensation Expense

Stock-based compensation expense was classified in the condensed consolidated statements of operations and comprehensive loss as follows:

 

 

 

Three Months Ended March 31,

 

(in thousands)

 

2021

 

 

2020

 

Research and development expense

 

$

482

 

 

$

78

 

General and administrative expense

 

 

1,350

 

 

 

124

 

Total stock-based compensation expense

 

$

1,832

 

 

$

202